Creative Biolabs-Immuno-oncology

Anti-DLL3 (clone DL31G2E) SynExpress E1-G-I10-K Modified CD8+ T cells (CAT#: ITS-1224-CR2128)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target DLL3 (clone DL31G2E). We employs the HBV (EF1α-GFP-IL-10-KpnI) vector components and the SynExpress system of the Introns Knockout/Negative feedback for a robust and sustained response against cancers.
Host
Humanized
Target
DLL3
Clone
DL31G2E
Species Reactivity
Mouse
Cell Source
Modified CD8+ T cells
Sensor Gene
GFP
Promoter
EF1α
Effector Gene
IL-10
Insertion Sites
KpnI
Gene Modification
Knockout
Modification Domain
Introns
Carrier Type
HBV
Transformation Accuracy
0.97
Cell Culture
Aseptic Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving